Search
Selected Filter
Displaying 231–240 of 504 news results
-
Foundation News
Mr. Ginsberg brings twenty-five years of rare disease corporate development, finance, strategy, and investment leadership experience.
-
Penn Vet’s William Beltran Elected to the National Academy of Medicine
Research NewsThe veterinary researcher’s canine studies are advancing promising retinal therapies toward clinical trials
-
Partner News
Acquisition significantly expands Janssen’s eye disease portfolio and strengthens its gene therapy capabilities. Late-stage AMD affects millions of people with no effective treatments currently available .
-
Foundation Fighting Blindness Launches ShopFightingBlindness.org
Foundation NewsThis official store offers branded apparel and merchandise designed to spread awareness and raise funds for the Foundation’s mission.
-
AGTC Announces Results for Achromatopsia Gene Therapy Clinical Trials
Research NewsThe company will continue enrolling younger patients in higher dosing groups.
-
Stargazer Pharmaceuticals Initiates a Phase 2a Clinical Trial for its Stargardt Disease Drug
In the PressThe Foundation Fighting Blindness Retinal Degeneration Fund is an investor in the company
-
SparingVision Raises €44.5 Million for Gene-Independent RP Therapy
Research NewsThe company is planning a clinical trial for its emerging neuroprotective treatment in 2021
-
RP Treatment Derived from Induced Pluripotent Stem Cells Advances into Clinical Trial
Research NewsThe stem cells were derived from mature blood cells and coaxed to become photoreceptors
